TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A physician’s commentary argues that persistent subjective cognitive decline can warrant a thorough evaluation and follow-up even when cognitive test scores remain in the normal range. It is not a diagnosis of Alzheimer’s: multiple health and life factors can affect thinking, and features such as recent, persistent memory concerns may call for closer assessment.
Geriatrician and memory-care physician Dr. Nathaniel Chin says persistent concerns about changes in memory or thinking deserve careful assessment even when testing falls within the normal range. In a commentary published by Being Patient on October 27, 2026, Chin describes subjective cognitive decline as a possible early window for evaluating Alzheimer’s risk and other causes, while emphasizing that the experience does not itself mean a person has Alzheimer’s disease.
Subjective cognitive decline (SCD) refers to a person’s continuing sense that their thinking has worsened compared with their own earlier abilities, despite comprehensive testing showing no objective impairment. Chin says normal scores can miss a meaningful change because tests often compare a person with others of similar age rather than with that person’s previous performance. Someone whose abilities were once well above average, for example, could decline and still score in the average range.
Chin distinguishes a brief screening from a more extensive evaluation. A screening test generally takes five to 15 minutes and samples a limited range of abilities. A comprehensive cognitive evaluation typically lasts an hour or more and examines areas including memory, language, attention and executive function. In Chin’s view, establishing a detailed baseline and repeating assessments over time can help clinicians determine whether someone is stable or showing a consistent decline.
The commentary also stresses that SCD has many possible explanations. Sleep problems, medications, depression or anxiety, medical illness, vascular disease, hearing loss, stress and normal aging can affect how sharp a person feels. Chin recommends investigating potential contributors and, when possible, including observations from someone who knows the person well. He says a normal test result should not automatically end follow-up when concerns persist.
When Memory Concerns Merit Follow-Up
The distinction matters because a person can notice a change before a test identifies impairment. Chin’s argument is not that everyone with memory concerns has Alzheimer’s, but that normal scores do not always resolve a persistent concern. Taking a history, checking for other causes and comparing results over time may give clinicians a more useful picture than a single screening result.
That approach may also help avoid two errors: treating a subjective concern as proof of disease, or dismissing it solely because one test is normal. Chin frames SCD as a clinical description, not an explanation. For readers and families, the practical point is that continuing changes can merit discussion with a health professional, while diagnosis requires more than a person’s worry or a checklist of risk features.
Products Worth Considering
LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
Levoit Core 400S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
The SCD-Plus Features
Chin refers to the “SCD plus” concept developed by psychiatrist Frank Jessen of the University of Cologne and colleagues in the international Subjective Cognitive Decline Initiative. It identifies features that may make subjective decline more concerning for possible early Alzheimer’s, including memory-focused concerns, onset within the past five years, onset at age 60 or older, worry about the change, persistence, seeking medical advice and confirmation from someone who knows the person well.
These features do not prove Alzheimer’s disease, Chin cautions. Their presence together may support closer attention, but they cannot establish a cause. He contrasts long-standing, intermittent word-finding worries associated with poor sleep or stress with a more recent and continuing memory change that a spouse also notices. Both people might test within the normal range, but the pattern and history would lead him to assess them differently.
What SCD Cannot Establish
SCD does not identify the cause of a person’s perceived change, and the SCD-plus features are not diagnostic. The source commentary describes several non-Alzheimer’s factors that can affect thinking, but it does not provide a way to determine from symptoms alone which factor is responsible for an individual.
The supplied material begins to discuss blood biomarkers, cerebrospinal fluid testing and amyloid PET as possible tools for selected patients, but it ends before explaining their use, limits or evidence. It therefore does not establish who should receive these tests, how they would change care, or what results would mean for a particular patient. Chin’s commentary also does not report new clinical-trial findings or a treatment recommendation for people with SCD.
Building a Baseline Over Time
For someone with persistent concerns, Chin describes a clinical approach that includes a thorough cognitive baseline, an assessment of possible contributing factors and follow-up testing to check for a pattern of change. Input from a spouse, relative or other person who knows the patient may add useful information when available. The commentary does not set a universal testing schedule or say that every person reporting a change needs specialist testing.
People concerned about memory or thinking can raise the pattern, timing and effect on daily life with a qualified health professional. Further assessment can help distinguish a subjective concern from measurable impairment and consider potential causes; an SCD label alone is not an Alzheimer’s diagnosis. The next step in any individual case depends on clinical evaluation, and the source does not announce a new guideline or policy change.
Key Questions
What is subjective cognitive decline?
SCD is a persistent feeling that memory or another thinking ability has declined from a person’s previous level, even though comprehensive cognitive testing does not show objective impairment.
Does subjective cognitive decline mean someone has Alzheimer’s?
No. Chin describes SCD as an experience, not a diagnosis or explanation. Sleep, stress, medications, mood, health conditions, hearing loss and normal aging can also affect how thinking feels.
Why might a normal test not settle the concern?
A score may be compared with other people of similar age rather than with the individual’s earlier abilities. Chin also notes that short screening tests assess a limited range of cognition; a comprehensive evaluation and repeat testing may provide more information when concerns continue.
Which SCD features may warrant closer attention?
The SCD-plus features include recent onset, memory-focused concerns, onset at age 60 or older, persistence, worry, seeking medical help and another person confirming the change. These features do not prove Alzheimer’s, but several together may support a closer clinical assessment.
Source: beingpatient.com
